Skip to content
Saturday, November 14, 2026
TrueVipExpress

Zimbabwe Rejects ‘One-Sided’ US Health Aid Agreement Over Data Apprehensions

Medical funding image
The proposed American funding was intended for initiatives for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a major US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years over Washington's request for confidential biological samples.

This rejection was revealed after a official document from December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "skewed".

An official representative has since clarified that the United States was seeking genetic material for research and commercial gain while was not willing to guarantee the resulting advantages from future medical innovations.

"We are forced to start the difficult and regrettable task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for more negotiations to reach a agreement agreeable to both sides so the country's critical HIV programme can be sustained.

Broader Context

This rejection follows a comparable case in Kenya, where a court suspended a related deal with the US following concerns were raised about the safety of citizens' medical information.

After resuming office last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to boost transparency and responsibility.

Based on statements, 16 nations in Africa have so far signed similar agreements, constituting over $18.3bn of fresh investment.

Details of the Rejected Deal

This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this cooperation might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador added.

However, official spokesman Nick Mangwana said the proposed deal was "unfair".

"Our nation was requested to surrender its genetic material and health information indefinitely, with no equivalent assurance of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," he stated.

"In essence, our nation would supply the basic resources for scientific discovery without any assurance that the end products would be accessible to our population if a future pandemic arise."

Sovereignty and International Frameworks

Mangwana further noted that the US's withdrawal from the global health body and its push of one-on-one deals were upending systems previously established through the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.

"This system is designed to guarantee that when a nation provides its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."

These objections regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We welcome ongoing discussions with our American counterparts on how future collaboration could be designed in a manner that honours the independence and dignity of both nations."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but recommended that negotiations should continue given that much of the nation's HIV programmes were funded by external financing.

"Where technical issues exist, such as those involving information security or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," the group added.

The halted deal highlights the ongoing debate between accepting much-needed international aid and protecting a country's data in an increasingly interconnected world.

Written by

Dana Watts

A travel enthusiast and luxury lifestyle writer with a passion for exploring exclusive destinations and sharing VIP travel insights.

TrueVipExpress

Type to search articles.